Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxysterol-binding protein 2 (OSBP2) is a lipid transfer protein that binds oxysterols (including 7-ketocholesterol), and plays important roles in cholesterol homeostasis, lipid transport, and regulation of cellular metabolism[3][5][1]. The protein contains a pleckstrin homology (PH) domain and an oxysterol-binding region, and alternative splicing produces multiple isoforms[3][5]. OSBP2 helps regulate the intracellular handling of cholesterol and oxysterols, potentially protecting cells from oxysterol cytotoxicity[3][2][5]. It also regulates signaling pathways such as β-catenin in preadipocytes, thereby influencing adipocyte differentiation, obesity risk, and energy metabolism[1]. Animal and cellular models suggest that OSBP2 disruption affects preadipocyte maturation, lipid droplet formation, and metabolic phenotypes[1]. OSBP2 is considered a potential therapeutic target, especially for obesity and hypercholesterolemia-related diseases[1].
Modulation of cholesterol transport Regulation or sequestration of cytotoxic oxysterols Regulation of preadipocyte differentiation via β-catenin signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol-binding protein 2 (OSBP2).